SAB Biotherapeutics Inc

NEW
NAS:SABS (USA)  
$ 3.9 +0.060 (+1.56%) 10:08 PM EST
At Loss
P/B:
1.45
Market Cap:
$ 354.85M
Enterprise V:
$ 257.35M
Volume:
343.10K
Avg Vol (2M):
826.76K
Trade In:
Volume:
343.10K
At Loss
Avg Vol (2M):
826.76K

SAB Biotherapeutics Inc (SABS) Dividend

SAB Biotherapeutics Inc (SABS) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -111.4%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: SABS Dividend

Does SAB Biotherapeutics Inc (SABS) pay a dividend?

SAB Biotherapeutics Inc (SABS) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't SAB Biotherapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. SAB Biotherapeutics Inc has returned capital to shareholders via buybacks at a rate of -111.4% over the past 3 years.

What are dividend-paying alternatives to SAB Biotherapeutics Inc?

For dividend-paying alternatives in SAB Biotherapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.